Data-centric artificial intelligence in oncology: a systematic review assessing data quality in machine learning models for head and neck cancer

J Adeoye, L Hui, YX Su - Journal of Big Data, 2023 - Springer
Abstract Machine learning models have been increasingly considered to model head and
neck cancer outcomes for improved screening, diagnosis, treatment, and prognostication of …

Prognosing post-treatment outcomes of head and neck cancer using structured data and machine learning: A systematic review

M Moharrami, P Azimian Zavareh, E Watson, S Singhal… - Plos one, 2024 - journals.plos.org
Background This systematic review aimed to evaluate the performance of machine learning
(ML) models in predicting post-treatment survival and disease progression outcomes …

[HTML][HTML] Hierarchical cluster analysis and nonlinear mixed-effects modelling for candidate biomarker detection in preclinical models of cancer.

D Hodson, H Mistry, J Yates, S Guzzetti… - European Journal of …, 2024 - Elsevier
Background Preclinical models of cancer can be of translational benefit when assessing
how different biomarkers are regulated in response to particular treatments. Detection of …

A Novel Method for Evaluating Early Tumor Response Based on Daily CBCT Images for Lung SBRT

W Luo, Z Xiu, X Wang, R McGarry, J Allen - Cancers, 2023 - mdpi.com
Simple Summary The assessment of tumor response is important in evaluating cancer
treatment and predicting clinical outcomes. The currently used response evaluation criteria …

Contribution of machine learning to tumor growth inhibition modeling for hepatocellular carcinoma patients under Roblitinib (FGF401) drug treatment

M Wilbaux, D Demanse, Y Gu, A Jullion… - CPT …, 2022 - Wiley Online Library
Abstract Machine learning (ML) opens new perspectives in identifying predictive factors of
efficacy among a large number of patients' characteristics in oncology studies. The objective …

Joint modeling of tumor dynamics and progression‐free survival in advanced breast cancer: Leveraging data from amcenestrant early phase I–II trials

M Cerou, HT Thai, L Deyme… - CPT …, 2024 - Wiley Online Library
A joint modeling framework was developed using data from 75 patients of early
amcenestrant phase I–II AMEERA‐1‐2 dose escalation and expansion cohorts. A semi …

[图书][B] Combining Mixed Effects Modeling with Sparse Regression for Model Selection Using Biological Time Series Data

S Rich - 2022 - search.proquest.com
By using the population level data of heterogeneous populations, statistical and
mathematical approaches, such as Lasso and mixed effects modeling, to identify variables …